ArticleMicrobiology spectrum2026
Comparative analysis of the effects of aztreonam combined with four β-lactamase inhibitors against carbapenem-resistant
Qing Meng, Chao Xu, Wujiao Li, Kunling Shen, Xiuhui Huang, Xiaoying Fu, Lintao Zhou, Yunsheng Chen, Fupin Hu, Heping Wang
Erratum issuedAbstract readComparative Study
In one paragraphArticle in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
10 authors.
Qing MengDepartment of Clinical Microbiology Laboratory, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.ORCID 0000-0002-1476-9051 Chao XuFirst Clinical Medical College, Ningxia Medical University, Yinchuan, Ningxia, China.
Wujiao LiDepartment of Clinical Microbiology Laboratory, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.
Kunling ShenDepartment of Respiratory Diseases, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.
Xiuhui HuangDepartment of Clinical Microbiology Laboratory, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.
Xiaoying FuDepartment of Clinical Microbiology Laboratory, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.
Lintao ZhouDepartment of Clinical Microbiology Laboratory, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.
Yunsheng ChenDepartment of Clinical Microbiology Laboratory, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.ORCID 0000-0002-8520-9852 Heping WangDepartment of Respiratory Diseases, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.ORCID 0000-0002-9527-1334 Funding
Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties SZGSP012Shenzhen Key Medical Discipline Construction Fund SZXK032
6 · The paper itselfAbstract
Indexed as
Anti-Bacterial AgentsAztreonambeta-Lactamase InhibitorsCarbapenem-Resistant EnterobacteriaceaeAzabicyclo CompoundsBacterial Proteinsbeta Lactam Antibioticsbeta-LactamasesCarbapenemsClavulanic AcidDrug Resistance, Multiple, BacterialDrug SynergismEnterobacteriaceae InfectionsHumansMicrobial Sensitivity TestsSulbactamAnti-Bacterial AgentsavibactamAzabicyclo CompoundsAztreonamBacterial Proteinsbeta Lactam Antibioticsbeta-Lactamase Inhibitorsbeta-LactamasesCarbapenemsClavulanic AcidSulbactamTazobactamaztreonam/avibactamcarbapenem-resistant Enterobacteralesclavulanic acidmetallo-β-lactamase
Identifiers
PMID41615154
PMCPMC12955434
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390